This episode is sponsored by Evercore, Davis Polk and Dawson Partners
The secondaries market sits at a crossroads. Never before have LPs been presented with such an array of different liquidity offerings to back. There are specialised secondaries funds focusing on healthcare, on impact investing, on real assets in Asia or on acquiring direct minority equity stakes in companies in India. There are funds focusing on writing large cheques to multi-billion-dollar single-asset continuation...
This episode is sponsored by Evercore, Davis Polk and Dawson Partners
The secondaries market sits at a crossroads. Never before have LPs been presented with such an array of different liquidity offerings to back. There are specialised secondaries funds focusing on healthcare, on impact investing, on real assets in Asia or on acquiring direct minority equity stakes in companies in India. There are funds focusing on writing large cheques to multi-billion-dollar single-asset continuation funds; and there are funds focusing on making late primary commitments to buyout funds that are still in their fundraising mode. In short, if you’re an LP looking to back a secondaries fund, you’re spoiled for choice.
In this special episode, we sit down with Nigel Dawn, global head of Evercore's Private Capital Advisory group; Leor Landa, head of the investment management practice at Davis Polk; and Yann Robard, managing partner at Dawson Partners. We discuss why the performance of continuation funds is key to the further growth and branching out of this part of the market, and why the market is undergoing the fastest pace of innovation it has ever seen.
View more
